ECM1
Basic information
Region (hg38): 1:150508062-150513789
Links
Phenotypes
GenCC
Source:
- lipoid proteinosis (Definitive), mode of inheritance: AR
- lipoid proteinosis (Strong), mode of inheritance: AR
- lipoid proteinosis (Strong), mode of inheritance: AR
- lipoid proteinosis (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Lipoid proteinosis | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Audiologic/Otolaryngologic; Biochemical; Dermatologic; Neurologic; Pulmonary | 5002423; 751090; 4087005; 11929856; 12603844; 19519837; 19734986; 21349189; 21791056; 21886756; 22182433 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (85 variants)
- Lipid_proteinosis (43 variants)
- not_provided (32 variants)
- ECM1-related_disorder (13 variants)
- Autism (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ECM1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004425.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 14 | ||||
missense | 83 | 98 | ||||
nonsense | 14 | |||||
start loss | 0 | |||||
frameshift | 10 | 15 | ||||
splice donor/acceptor (+/-2bp) | 3 | |||||
Total | 21 | 10 | 87 | 19 | 7 |
Highest pathogenic variant AF is 0.000125781
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ECM1 | protein_coding | protein_coding | ENST00000369049 | 10 | 5728 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.66e-14 | 0.174 | 125647 | 0 | 101 | 125748 | 0.000402 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.224 | 336 | 325 | 1.03 | 0.0000198 | 3684 |
Missense in Polyphen | 118 | 115.23 | 1.024 | 1355 | ||
Synonymous | 0.0945 | 121 | 122 | 0.989 | 0.00000628 | 1155 |
Loss of Function | 1.01 | 24 | 30.0 | 0.801 | 0.00000192 | 287 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000572 | 0.000572 |
Ashkenazi Jewish | 0.000700 | 0.000695 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.000278 | 0.000277 |
European (Non-Finnish) | 0.000612 | 0.000536 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000297 | 0.000294 |
Other | 0.000490 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in endochondral bone formation as negative regulator of bone mineralization. Stimulates the proliferation of endothelial cells and promotes angiogenesis. Inhibits MMP9 proteolytic activity. {ECO:0000269|PubMed:11165938, ECO:0000269|PubMed:11292659, ECO:0000269|PubMed:16512877}.;
- Pathway
- Platelet degranulation ;Response to elevated platelet cytosolic Ca2+;Platelet activation, signaling and aggregation;Hemostasis
(Consensus)
Recessive Scores
- pRec
- 0.301
Intolerance Scores
- loftool
- 0.427
- rvis_EVS
- -0.27
- rvis_percentile_EVS
- 34.82
Haploinsufficiency Scores
- pHI
- 0.148
- hipred
- N
- hipred_score
- 0.173
- ghis
- 0.422
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0999
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ecm1
- Phenotype
- immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- ossification;angiogenesis;positive regulation of endothelial cell proliferation;negative regulation of cytokine-mediated signaling pathway;chondrocyte development;platelet degranulation;regulation of type 2 immune response;endochondral bone growth;regulation of transcription by RNA polymerase II;inflammatory response;signal transduction;negative regulation of peptidase activity;negative regulation of bone mineralization;biomineral tissue development;positive regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of angiogenesis;regulation of T cell migration
- Cellular component
- extracellular region;extracellular matrix;platelet dense granule lumen;collagen-containing extracellular matrix;extracellular exosome
- Molecular function
- protease binding;interleukin-2 receptor binding;extracellular matrix structural constituent;protein binding;protein C-terminus binding;enzyme binding;laminin binding